Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
10/2005
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679545A Andrographolide dispersing tablets
10/12/2005CN1679511A Vaginal gel tablets
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222319C Composition for IVF
10/12/2005CN1222302C Traditional Chinese medicine for curing gynopathy
10/12/2005CN1222293C NKT cell activators contg. alpha-glycosylceramides
10/12/2005CN1222292C Fulvestrant formulation
10/12/2005CN1222283C Methods of rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
10/12/2005CN1222279C Prolonged release bioadhesive vaginal gel dosage form
10/11/2005US6953854 Process for preparing crystalline Form I of cabergoline
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953800 Quinazoline derivatives
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953787 5HT2C receptor modulators
10/11/2005US6953785 Estra-1,3,5(10)-triene derivatives
10/06/2005WO2005092353A1 Hop extracts, production and use thereof
10/06/2005WO2005092346A1 Using combination of estrogen and progestin with ultra low dose for long term oral contraception
10/06/2005WO2005092329A1 Topical and intravaginal microbicidal antiparasitic compositions comprising quassinoids or quassinoid-containing plant extracts
10/06/2005WO2005092309A1 Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222273 Treatment of female sexual dysfunction
10/06/2005US20050222214 Administering conjugate having a polyethylene glycol (PEG) moiety covalently bound to the serine residue of antide for therapy of hormonal dependent cancer, endometriosis, uterine fibroids, uterine myoma, and leutinizing hormone (LH) surge in woman undergoing in vitro fertilization
10/06/2005US20050222206 Pyridinoylpiperidines as 5-ht1f agonists
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222181 Compounds in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
10/06/2005US20050222174 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone
10/06/2005US20050222170 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005US20050222124 Benzenesulfonamide derivatives as antipsychotic agents
10/06/2005US20050222114 Use of new etonogestrel esters
10/06/2005US20050222113 New etonogestrel esters
10/06/2005US20050222105 Nitric ester derivatives of hormones such as progesterone, used for preventing premature labor, increasing cervical dilatation, in hormone replacement therapy, as hypeortensive agents and for treating dysmenorrhea
10/06/2005US20050222100 Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm
10/06/2005US20050222099 Pregnane steroids for use in the treatment of cns disorders
10/06/2005US20050222091 Use of tyrosine kinase inhibitors for treating cns disorders
10/06/2005US20050222087 Hedgehog antagonists that inhibit the hedgehog pathway in a smoothened gain-of-function cell with an IC50 within a factor of 20, 10, or even a factor of 5, of the IC50 with which they inhibit the hedgehog pathway in a patched-null cell
10/06/2005US20050222041 oligopeptides capable of stimulating neural cell adhesion molecule (NCAM) signalling and/or interfering with cell adhesion, used for treatment of nervous system disorders
10/06/2005US20050220905 Tribulus terrestris, Turnera diffusa and Cinnamon cassia extracts in a precise weight ratio with Ginkgo biloba extract and a carrier or excipient; impotence, erectile dysfunction; reduced libido; frigidity; anorgasmia; side effect reduction; vasodilation; dopaminergic agents; phosphodiesterase inhibitor
10/06/2005US20050220900 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
10/06/2005US20050220855 Matrix for administering ergoline compounds such as lisuride; restless leg syndrome; circadian rhythm disorders; Parkinson's disease
10/06/2005US20050220715 Methods and compositions for improving drug safety
10/06/2005DE102004012830A1 Hopfenextrakte, Herstellung und Verwendung Hop extracts, production and use
10/06/2005CA2556459A1 Extended cycle multiphasic oral contraceptive method
10/05/2005EP1581821A2 Network-assisted global positioning systems, methods and terminals including doppler shift and code phase estimates
10/05/2005EP1581247A1 Methods and compositions for treating polycystic ovary syndrome
10/05/2005EP1581223A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
10/05/2005EP1325008B1 Piperazine derivatives
10/05/2005EP1257280B1 Pharmaceutical combination of micronised drospirenone and an estrogen for hormone replacement therapy
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1158978B1 Medicament against dysmenorrhoea and premenstrual syndrome comprising lidocaine
10/05/2005CN1678626A Estrieno[3, 2-b]/[3, 4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678576A Pyrrolidine derivatives as oxytocin antagonists
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678332A Novel therapeutic use of polypodium extracts
10/05/2005CN1678324A Estrogen replacement regimen
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1676151A Chinese medicine preparation for inivigorating blood circulation for women
10/05/2005CN1676130A Water-soluble medicine sublingual-medicating formulation
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/04/2005US6951916 Melanocortin receptor ligands
10/04/2005US6951883 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951858 Substituted 1,2,4-triazine-3,5-diones; male and female sex hormone related conditions
10/04/2005US6951855 vascular damaging agents
10/04/2005US6951850 Dipeptide derivatives
10/04/2005US6951654 Intravaginal drug delivery devices for the administration of an antimicrobial agent
10/04/2005CA2146763C Quinolone and acridinone derivatives for the treatment of urinary incontinence
09/2005
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005WO2005089782A1 Process for producing fermented stevia solution, health drink for livestock and udder wasiing liquor for livestock
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005US20050215869 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
09/29/2005US20050215617 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
09/29/2005US20050215605 Preterm labor, premature birth, dysmenorrhea; inhibitors of the prostaglandin F2 alpha receptor; e.g. 3-([1,1'-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide
09/29/2005US20050215592 Methods for assessing, improving, or maintaining urogenital health in postmenopausal woman
09/29/2005US20050215559 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders
09/29/2005US20050215528 Gnrh agonist combination drugs
09/29/2005US20050214384 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
09/29/2005US20050214364 Products and methods for treating vaginal infections
09/29/2005US20050214330 Process for producing sustained-release composition
09/29/2005US20050214281 G-protein coupled receptor
09/29/2005CA2843966A1 Follicle stimulating hormone superagonists
09/29/2005CA2563345A1 Follicle stimulating hormone superagonists
09/29/2005CA2562388A1 Emulsion-stabilized preparation
09/28/2005EP1579856A1 Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
09/28/2005EP1578480A2 Antagonists for human prolactin
09/28/2005EP1578427A1 Use of gnrh agonists to support the luteal phase during infertility treatment
09/28/2005EP1448521B1 Derivatives of andrimide and moiramide b having antibacterial properties
09/28/2005CN1675354A In vitro fertilisation
09/28/2005CN1675229A Sulfur-containing phospholipid derivatives
09/28/2005CN1675224A Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675210A Substituted 2, 4-dihydro-pyrrolo[3, 4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
09/28/2005CN1675208A Novel fused imidazole derivative
09/28/2005CN1675205A Novel quinuclidine derivatives and their use
1 ... 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 ... 557